CMV Immunity Monitoring in Lung Transplant Recipients
Condition: Lung Transplant; Complications Interventions: Device: Cytomegalovirus T Cell Immunity Panel (CMV-TCIP); Diagnostic Test: Donor-Derived Cell-Free DNA (dd-cfDNA) Assay; Drug: Valganciclovir Sponsors: NYU Langone Health; Viracor Eurofins Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials